GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » Short-Term Debt & Capital Lease Obligation

Skinvisible (Skinvisible) Short-Term Debt & Capital Lease Obligation : $0.81 Mil (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Skinvisible Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Skinvisible's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.81 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Skinvisible's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $5.37 Mil.

Skinvisible Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Skinvisible's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skinvisible Short-Term Debt & Capital Lease Obligation Chart

Skinvisible Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.82 0.50 0.47 0.48

Skinvisible Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.47 0.48 0.48 0.81

Skinvisible Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Skinvisible Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Skinvisible's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Skinvisible (Skinvisible) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » Short-Term Debt & Capital Lease Obligation
Comparable Companies
RCKY SHOO DBI MCRAA VRA CROX WEYS DECK BIRK ONON PG XPAR:OR LSE:ULVR CL BOM:500696 EL KMB LSE:RKT KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
6320 South Sandhill Road, Suite 10, Las Vegas, NV, USA, 89120
Website
https://www.skinvisible.com
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
Executives
St James David M director 3395 S. JONES BLVD., #169, LAS VEGAS NV 89146
Doreen Mcmorran 10 percent owner 6320 S. SANDHILL RD UNIT 10, LAS VEGAS NV 89120
Brian Piwek director 9014 GLENEAGLE DRIVE, BLAINE WA 98230
E Greg Mccartney director #307-15338 18TH AVENUE, SURREY BC A1 V4A 1W8
Jost Steinbruchel director 7, RUE DES BATTOIRS, POBOX #214, 1211 GENEVA 4 V8 000000
Robert F Lutz director, 10 percent owner
Terry Howlett director, 10 percent owner, officer: President & Chief Exec.Officer 6320 S. SANDHILL ROAD, SUITE #10, LAS VEGAS NV 89120
Skinvisible Inc director, 10 percent owner, officer: President 6320 S SANDHILL ROAD, SUITE 10, LAS VEGAS NV 89120
Lutz Family Trust 10 percent owner 8322 WEST TONTO LANE, PEORIA AZ 85382